Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan 10 mg vs placebo in non-erosive gastroesophageal reflux disease (NERD)
jRCT2080223358Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Non-erosive Gastroesophageal Reflux Disease (NERD) comparing vonoprazan 10 mg with placebo (2 arms). Started Oct 2016; status: completed.
02
Drugs
vonoprazan
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on jRCT2080223358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223358.